| Evofem Biosciences is a biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health. Co. is utilizing its proprietary Multipurpose Vaginal pH Regulator (MVP-R) platform to product candidates for several potential indications, including prevention of pregnancy and prevention of certain sexually transmitted infections. Co. is developing its primary MVP-R product candidate, Phexxi, a non-hormonal, woman-controlled vaginal gel, for three potential indications: prevention of pregnancy, prevention of urogenital Chlamydia trachomatis infection and prevention of urogenital Neisseria gonorrhoeae infection. We show 13 historical shares outstanding datapoints in our EVFM shares outstanding history coverage, used to compute EVFM market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing EVFM market cap history over the course of time is important for investors
interested in comparing EVFM's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of EVFM versus a peer is one thing; comparing
EVFM market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like EVFM can fluctuate over the course of history.
With this page we aim to empower investors researching EVFM by allowing them to research the EVFM market cap history.